The author conducted an analysis of randomized, double blind, placebo-controlled studies of progesterone or progestins in women diagnosed with PMS. Oral micronized progesterone and the progestogens MPA, norethisterone and dydrogesterone, all showed a marginal benefit over placebo in symptom reduction.
Author: Yonkers K.
Publication Year: 2002
Citation: Evid Based Ment Health 2002;5(2):56.